Received Feb 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Fever; Tiredness; Muscle pain; This non-serious case was reported by a nurse via call center representative and described the occurrence of fever in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fever (Verbatim: Fever), tiredness (Verbatim: Tiredness) and muscle pain (Verbatim: Muscle pain). The outcome of the fever, tiredness and muscle pain were unknown. It was unknown if the reporter considered the fever, tiredness and muscle pain to be related to Shingrix. It was unknown if the company considered the fever, tiredness and muscle pain to be related to Shingrix. Additional Information: GSK receipt Date: 12-FEB-2025 and 14-FEB-2025 The reporter mentioned during the call as an example that his mother felt muscle pain, tiredness and fever after receiving Shingrix. The reporter did not had lot number for the vaccine and refused to provide any additional details about this case and declined consent to follow up with Safety Team in regards to his mother's symptoms since he mentioned that was not the reason why he was calling and he felt it was a violation to his mother's privacy. Did not consent to follow-up.; Sender's Comments: US-GSK-US2025018347:same reporter